The Atrial Fibrillation Surgery Market is expected to register a CAGR of nearly 12.2% during the forecast period.
The COVID-19 patients with cardiovascular disorders are at high risk and are most vulnerable to multiple organ failure including myocarditis and rhythm disturbance. The data from Wuhan, China has indicated that arrhythmia and acute cardiac injury were amongst the most prevalent heart complications in confirmed-positive cases of COVID 19. Further, the February 2020 case report in the Journal of the American Medical Association (JAMA) identified common complications, such as shock (8.7%), acute respiratory distress syndrome (19.6%), arrhythmia (16.7%), and acute cardiac injury (17.2%) among hospitalized patients. Moreover, patients who received care in the ICU were more likely to have one of these complications than non-ICU patients.
Click Here to Download Sample Report >> https://www.sdki.jp/sample-request-113328
Moreover, owing to the evolving public health crisis of COVID-19, remote monitoring allows clinicians to maintain necessary patient rapport with their healthcare provider when required. Health care providers can access information remotely about a patient’s health while the patient is at home, which will reduce the need for hospital visits and minimizing the risk of exposure to COVID-19. The article ‘Home Monitoring of Cardiac Devices in the Era of COVID-19’, published in 2020 concludes that new technologies and digital platforms to aid in remote care should be developed and further research on the role of telehealth, continuous data collecting, advanced automotive features, and remote patient monitoring is needed to guide best practices, which may fuel the growth of studied market.
The atrial fibrillation market is driven by rising prevalence of obesity and heart diseases across the globe. Additionally, heart diseases are one of the major cause of mortality across the globe and due to the changing lifestyle, the number of people suffering from heart diseases is growing rapidly.
Atrial Fibrillation (AFib) is the most prevalent chronic arrhythmia in patients above 65 years of age. As per the Centers for Disease Control and Prevention (CDC) estimates around 12.1 million people in the United States will have AFib by 2030. With the growth in the aging population, this number is expected to increase. Thus, the increasing incidences of CVD and atrial fibrillation are expected to augment the growth of the market studied and is posing a high burden on the economies of various countries due to the high cost of treatment. Hence, owing to the aforementioned factors, the market studied is expected to grow in the forecast period.
Atrial Fibrillation Surgery Market
Varicose Veins Treatment Market
Liver Diseases Therapeutics Market
Radioimmunoassay Market
Schizophrenia Drugs Market
Vietnam Aluminium Market
Optometry Equipment Market
Weight Management Devices Market
Animal Biotechnology Market
Track and Trace Solutions Market
